Researchers at the National Institute of Standards and Technology (www.nist.gov) have developed a new method to produce uniform, self-assembled nanocells for drug therapies, such as chemotherapy, in which dosage depends critically on the size of the nanocells. The new method uses micrometer-size channels etched into a device to produce self-assembled liposomes—a type of artificial nanocell—of specific sizes from 100 to 240 nm. A stream of lipids dissolved in alcohol is directed at an intersection of two channels while a water-based liquid containing medicines or other substances is sent toward the lipid stream from two opposing directions. Self-assembled nanocells are formed when the lipids surround the water rather than mixing with it.
A new service lets engineers and orthopedic surgeons design and 3D print highly accurate, patient-specific, orthopedic medical implants made of metal -- without owning a 3D printer. Using free, downloadable software, users can import ASCII and binary .STL files, design the implant, and send an encrypted design file to a third-party manufacturer.
For industrial control applications, or even a simple assembly line, that machine can go almost 24/7 without a break. But what happens when the task is a little more complex? That’s where the “smart” machine would come in. The smart machine is one that has some simple (or complex in some cases) processing capability to be able to adapt to changing conditions. Such machines are suited for a host of applications, including automotive, aerospace, defense, medical, computers and electronics, telecommunications, consumer goods, and so on. This discussion will examine what’s possible with smart machines, and what tradeoffs need to be made to implement such a solution.